Key result
Complete endovascular revascularization shows no benefit over incomplete revascularization for survival or repeat procedures.
Why the study?
Comparisons of remote results between anatomically complete and incomplete myocardial revascularization are scarce and ambiguous, with low ejection fraction typically being an exclusion criterion.
Does complete myocardial endovascular revascularization improve echocardiographic parameters, repeat revascularization rates, and survival compared to incomplete revascularization in patients with ischaemic heart disease and LVEF < 35%?
Cohort (n=151)
No
Does complete myocardial endovascular revascularization improve echocardiographic parameters, repeat revascularization rates, and survival compared to incomplete revascularization in patients with ischaemic heart disease and LVEF < 35%?
In patients with ischaemic heart disease and severe left ventricular dysfunction (LVEF < 35%), incomplete endovascular revascularization appears to be as effective as complete revascularization in terms of remote survival and repeat revascularization rates.
Answers are grounded in this paper and cite their sources.
Incomplete revascularization may suffice in severe LV dysfunction; leaves open whether complete confers benefit in randomized trials.
Despite the present-day level of the development of cardiac surgery, a low left ventricular ejection fraction (LLVEF) is an important independent predictor of high complication rates and increased in-hospital mortality related to open surgical interventions. The method of myocardial endovascular revascularization is associated with the lowest rates of both intraoperative and early postoperative complications. However, percutaneous coronary intervention (PCI) does not always make it possible to perform anatomically complete myocardial revascularization. Comparisons of the remote results of anatomically complete and incomplete revascularization of the myocardium in the world literature seem to be extremely scarce and ambiguous, with a low ejection fraction in the majority of cases being an exclusion criterion. In order to elucidate these problems we carried out a prospective, single-centre study, including a total of 151 patients suffering from ischaemic heart disease with a left ventricular ejection fraction of less than 35%, who were subjected to myocardial endovascular revascularization. The patients were divided into 2 groups: those with complete (n=87) and incomplete (n=64) revascularization, followed by comparing the alterations in the echocardiographic parameters, assessing the incidence of repeat myocardial revascularization due to a relapse of the clinical course of angina pectoris, and the survival rate in the remote period. The obtained findings were suggestive of efficacy of both complete and incomplete endovascular revascularization of the myocardium in patients with a low left ventricular ejection fraction (LLVEF), with no statistically significant differences between the patients of both groups in the examined parameters revealed.
No takes yet. Share an insight, caveat, or question.
Базылев et al. (2019) conducted a cohort in ischaemic heart disease with a left ventricular ejection fraction of less than 35% (n=151). Complete myocardial endovascular revascularization vs. Incomplete myocardial endovascular revascularization was evaluated on Alterations in echocardiographic parameters, incidence of repeat myocardial revascularization, and survival rate in the remote period. Complete and incomplete myocardial endovascular revascularization showed no significant differences in echocardiographic parameters, repeat revascularization, or survival.
Synapse has enriched 10 related papers. Consider them for comparative context: